168 related articles for article (PubMed ID: 19458171)
41. Protein kinase A phosphorylation activates Vpr-induced cell cycle arrest during human immunodeficiency virus type 1 infection.
Barnitz RA; Wan F; Tripuraneni V; Bolton DL; Lenardo MJ
J Virol; 2010 Jul; 84(13):6410-24. PubMed ID: 20392842
[TBL] [Abstract][Full Text] [Related]
42. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.
Dampier W; Antell GC; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; James T; Devlin KN; Giovannetti T; Libon DJ; Szep Z; Ehrlich GD; Wigdahl B; Krebs FC
J Neurovirol; 2017 Feb; 23(1):113-124. PubMed ID: 27400931
[TBL] [Abstract][Full Text] [Related]
43. Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R.
Iordanskiy S; Zhao Y; Dubrovsky L; Iordanskaya T; Chen M; Liang D; Bukrinsky M
J Virol; 2004 Sep; 78(18):9697-704. PubMed ID: 15331702
[TBL] [Abstract][Full Text] [Related]
44. Identification of SNF2h, a chromatin-remodeling factor, as a novel binding protein of Vpr of human immunodeficiency virus type 1.
Taneichi D; Iijima K; Doi A; Koyama T; Minemoto Y; Tokunaga K; Shimura M; Kano S; Ishizaka Y
J Neuroimmune Pharmacol; 2011 Jun; 6(2):177-87. PubMed ID: 21519849
[TBL] [Abstract][Full Text] [Related]
45. Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx.
Cassiday PA; DePaula-Silva AB; Chumley J; Ward J; Barker E; Planelles V
Virology; 2015 Feb; 476():19-25. PubMed ID: 25499532
[TBL] [Abstract][Full Text] [Related]
46. Regulation of the HIV-1 promoter by HIF-1α and Vpr proteins.
Deshmane SL; Amini S; Sen S; Khalili K; Sawaya BE
Virol J; 2011 Oct; 8():477. PubMed ID: 22023789
[TBL] [Abstract][Full Text] [Related]
47. Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells.
Müller B; Tessmer U; Schubert U; Kräusslich HG
J Virol; 2000 Oct; 74(20):9727-31. PubMed ID: 11000245
[TBL] [Abstract][Full Text] [Related]
48. Human immunodeficiency virus (HIV-1) Vpr induced downregulation of NHE1 induces alteration in intracellular pH and loss of ERM complex in target cells.
Janket ML; DeRicco JS; Borowski L; Ayyavoo V
Virus Res; 2007 Jun; 126(1-2):76-85. PubMed ID: 17349711
[TBL] [Abstract][Full Text] [Related]
49. Retrotransposition and senescence in mouse heart tissue by viral protein R of human immunodeficiency virus-1.
Ueno M; Matsunaga A; Teratake Y; Ishizaka Y
Exp Mol Pathol; 2020 Jun; 114():104433. PubMed ID: 32243892
[TBL] [Abstract][Full Text] [Related]
50. Evolution of a concept: From accessory protein to key virulence factor, the case of HIV-1 Vpr.
Wallet C; Rohr O; Schwartz C
Biochem Pharmacol; 2020 Oct; 180():114128. PubMed ID: 32619426
[TBL] [Abstract][Full Text] [Related]
51. Characterization of a leucine-zipper-like domain in Vpr protein of human immunodeficiency virus type 1.
Wang L; Mukherjee S; Narayan O; Zhao LJ
Gene; 1996 Oct; 178(1-2):7-13. PubMed ID: 8921884
[TBL] [Abstract][Full Text] [Related]
52. HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release.
Chutiwitoonchai N; Siarot L; Takeda E; Shioda T; Ueda M; Aida Y
PLoS One; 2016; 11(9):e0163100. PubMed ID: 27648839
[TBL] [Abstract][Full Text] [Related]
53. Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA.
Poon B; Chen IS
J Virol; 2003 Apr; 77(7):3962-72. PubMed ID: 12634356
[TBL] [Abstract][Full Text] [Related]
54. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
Yoshizuka N; Yoshizuka-Chadani Y; Krishnan V; Zeichner SL
J Virol; 2005 Sep; 79(17):11366-81. PubMed ID: 16103188
[TBL] [Abstract][Full Text] [Related]
55. Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr.
Mansky LM; Preveral S; Le Rouzic E; Bernard LC; Selig L; Depienne C; Benarous R; Benichou S
Virology; 2001 Mar; 282(1):176-85. PubMed ID: 11259200
[TBL] [Abstract][Full Text] [Related]
56. Insights into the biology of HIV-1 viral protein R.
Sherman MP; De Noronha CM; Williams SA; Greene WC
DNA Cell Biol; 2002 Sep; 21(9):679-88. PubMed ID: 12396611
[TBL] [Abstract][Full Text] [Related]
57. Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr.
Tungaturthi PK; Sawaya BE; Singh SP; Tomkowicz B; Ayyavoo V; Khalili K; Collman RG; Amini S; Srinivasan A
Biomed Pharmacother; 2003 Jan; 57(1):20-4. PubMed ID: 12642033
[TBL] [Abstract][Full Text] [Related]
58. Defining the roles for Vpr in HIV-1-associated neuropathogenesis.
James T; Nonnemacher MR; Wigdahl B; Krebs FC
J Neurovirol; 2016 Aug; 22(4):403-15. PubMed ID: 27056720
[TBL] [Abstract][Full Text] [Related]
59. HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated Neuroinflammation.
Mamik MK; Hui E; Branton WG; McKenzie BA; Chisholm J; Cohen EA; Power C
J Neuroimmune Pharmacol; 2017 Jun; 12(2):233-248. PubMed ID: 27726055
[TBL] [Abstract][Full Text] [Related]
60. Viral protein R of HIV-1.
Bukrinsky M; Adzhubei A
Rev Med Virol; 1999; 9(1):39-49. PubMed ID: 10371671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
